Bourbon Pointu (Coffea arabica)

Bourbon Pointu is a rare Coffea arabica cultivar containing exceptionally low caffeine content at 0.6% compared to regular coffee's 1.2-1.5%. It contains typical arabica polyphenols including chlorogenic acids, though no clinical studies have evaluated its specific health effects.

Origin & History

Bourbon Pointu is a rare natural mutation of Coffea arabica discovered in 1771 on Réunion Island (formerly Bourbon Island), characterized by distinctive pointed seeds and naturally low caffeine content (0.6% vs standard Arabica's 1.2-1.4%). The beans are produced through selective hand-picking of ripe cherries, followed by wet-processing and sun-drying.

Historical & Cultural Context

Bourbon Pointu was prized in the court of Louis XV in 18th-century France for its delicate taste, exceptional aroma, and fruity notes including orange, tangerine, and lychee. Nearly extinct until recent revival by family producers, its historical use was gastronomic rather than medicinal, with no links to traditional medicine systems.

Health Benefits

• No specific health benefits documented - no human clinical trials exist for Bourbon Pointu
• Lower caffeine content (0.6%) may reduce caffeine-related side effects compared to regular coffee - evidence quality: theoretical only
• Contains polyphenols typical of Arabica coffee - evidence quality: no specific studies on this cultivar
• High sucrose content contributes to natural sweetness without added sugars - evidence quality: compositional data only
• May be suitable for caffeine-sensitive individuals - evidence quality: based on chemical analysis, not clinical data

How It Works

Bourbon Pointu contains chlorogenic acids that may inhibit glucose-6-phosphatase and reduce hepatic glucose production, similar to other arabica varieties. The significantly reduced caffeine content (0.6%) provides minimal adenosine receptor antagonism, potentially reducing typical caffeine-mediated effects on the central nervous system. Polyphenolic compounds may activate antioxidant pathways through Nrf2 transcription factor modulation.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses specific to Bourbon Pointu were identified in the research. While general coffee research exists (e.g., PMID 28628448 on caffeine effects, PMID 34501747 on polyphenols), none isolate this specific low-caffeine cultivar variant.

Clinical Summary

No human clinical trials specifically examining Bourbon Pointu exist in the scientific literature. Research on this rare cultivar is limited to agricultural and chemical composition studies documenting its unique low-caffeine profile. General arabica coffee research suggests potential benefits from chlorogenic acid content, but these findings cannot be directly applied to Bourbon Pointu without specific studies. The evidence base remains entirely theoretical for health applications.

Nutritional Profile

Bourbon Pointu (Laurina mutation of Coffea arabica) shares the base nutritional matrix of Arabica coffee with several quantified distinctions. Per 240ml brewed cup (using ~10g ground coffee): Caffeine: approximately 50-70mg (0.6% dry weight vs. 1.2-1.5% in standard Arabica), roughly half the caffeine of conventional arabica brews. Sucrose: 7-9% of green bean dry weight (among the highest of any arabica cultivar), which degrades to glucose and fructose during roasting and contributes to perceived sweetness and caramel notes. Chlorogenic acids (CGA): approximately 250-350mg per cup, primarily 5-caffeoylquinic acid (5-CQA), consistent with arabica norms; no cultivar-specific CGA data exists so standard arabica ranges apply. Trigonelline: approximately 80-120mg per cup (pre-roasting ~1.0-1.2% dry weight), partially converting to niacin (vitamin B3) during roasting, yielding an estimated 0.5-1.0mg niacin per cup. Lipids: approximately 0.6-1.2g per cup (diterpenes cafestol and kahweol present, quantities dependent on brew method — filtered coffee retains minimal amounts). Potassium: approximately 100-120mg per cup. Magnesium: approximately 7-10mg per cup. Protein-derived compounds: free amino acids including glutamic acid and alanine contribute to flavor; total nitrogen ~1.5-2.0% of green bean dry weight. Fiber: negligible in brewed form (<0.5g). The elevated sucrose and reduced caffeine content are the two best-documented chemical distinctions of this cultivar; all other values are extrapolated from arabica species data due to absence of Bourbon Pointu-specific analytical studies.

Preparation & Dosage

No clinically studied dosage ranges are available. Bourbon Pointu is consumed as roasted whole beans or ground coffee without standardization to specific compounds. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Regular Arabica coffee, L-theanine, green tea extract, chicory root, dandelion root

Safety & Interactions

Bourbon Pointu appears generally safe for healthy adults given its extremely low caffeine content, though specific safety data is unavailable. The reduced caffeine may minimize interactions with medications like adenosine, lithium, or stimulants that typically interact with regular coffee. Pregnant women should still exercise caution despite lower caffeine levels, as no pregnancy safety studies exist. Individuals with coffee allergies should avoid Bourbon Pointu as it contains the same allergenic proteins as other arabica varieties.